Tirzepatide Research Profile Overview
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist peptide developed for metabolic research applications. This synthetic peptide demonstrates high affinity binding to both incretin hormone receptors, making it a valuable tool for investigating complex metabolic signalling pathways in laboratory environments. Research institutions worldwide examine Tirzepatide’s unique dual-agonist properties to better understand incretin biology and glucose homeostasis mechanisms. The compound’s molecular design incorporates structural modifications that enhance receptor selectivity and plasma stability in experimental models, positioning it as an essential research tool for scientists studying metabolic disorders and pancreatic function at Stroid UK Shop.
Laboratory Research Applications
Research teams investigate Tirzepatide across multiple metabolic study areas, with particular focus on its dual incretin receptor activation properties. The compound’s ability to simultaneously engage GLP-1 and GIP receptors provides researchers with a unique model for examining incretin pathway crosstalk and downstream signalling cascades. Laboratory studies explore how Tirzepatide influences insulin secretion patterns, glucagon suppression, and gastric emptying rates in controlled experimental environments. Scientists within the tirzepatide research category utilise this compound to analyse metabolic flux changes and energy expenditure modulations. Additional research applications include investigating the compound’s effects on appetite regulation centres, examining its influence on lipid metabolism pathways, and studying its potential neuroprotective properties in neural tissue models. These comprehensive research protocols help advance understanding of incretin hormone biology and metabolic syndrome pathogenesis.
Compound Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | 4813.5 g/mol |
| Peptide Length | 39 amino acids |
| Purity | ≥98% (HPLC verified) |
| Form | Lyophilised powder |
| Storage | -20°C, desiccated |
| Solubility | Water, bacteriostatic water |
| CAS Number | 2023788-19-2 |
Research teams studying peptide hormones frequently explore compounds within our comprehensive peptides collection to establish comparative metabolic profiles. Scientists investigating broader anabolic research applications often examine complementary compounds in our SARMs research category to understand diverse molecular mechanisms affecting cellular energy metabolism and tissue remodelling processes.
Research Compliance Statement
This Tirzepatide research compound is supplied exclusively for in-vitro laboratory research purposes by qualified research institutions and licensed facilities. The product is not intended for human consumption, therapeutic applications, or any form of in-vivo administration. Research teams must follow institutional guidelines for peptide hormone handling, maintain proper storage conditions, and ensure compliance with local research regulations. All investigations should be conducted within approved laboratory environments using appropriate safety protocols and analytical equipment.
